OP 40 (Oxycodone Hydrochloride Extended-Release 40 mg)

Pill with imprint OP 40 is Yellow, Round and has been identified as Oxycodone Hydrochloride Extended-Release 40 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Oxycodone is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. FDA has not classified the drug for risk during pregnancy. Oxycodone 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for OP 40

Oxycodone hydrochloride extended-release 40 mg OP 40

Oxycodone hydrochloride extended-release 40 mg OP 40 Front

Oxycodone Hydrochloride Extended-Release

Imprint: OP 40
Strength: 40 mg
Color: Yellow
Size: 7.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Narcotic analgesics
Pregnancy Category: N - Not classified
CSA Schedule: 2 - High potential for abuse
Labeler / Supplier: Teva Pharmaceuticals USA, Inc.
Inactive Ingredients: butylated hydroxytoluene, polyethylene glycol 400, magnesium stearate, titanium dioxide, polysorbate 80, ferric oxide yellow
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00093-5733	Teva Pharmaceuticals USA, Inc.
59011-0440	Purdue Pharma LP
49884-0138	Par Pharmaceutical, Inc.
00781-5767	Sandoz Inc.
00591-2693	Watson Pharmaceuticals, Inc.
63304-0683	Ranbaxy Pharmaceuticals Inc.
00115-1560	Global Pharmaceuticals
52959-0396	H.J. Harkins Company, Inc. (repackager)